The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACHILLION PHARMACEUTICALS | COM | 00448Q201 | 1,223 | 266,500 | SH | SOLE | 266,500 | 0 | 0 | ||
ADAMIS PHARMACEUTICALS CORP | COM NEW | 00547W208 | 127 | 24,401 | SH | SOLE | 24,401 | 0 | 0 | ||
ADVAXIS INC | COM NEW | 007624208 | 1,603 | 247,000 | SH | SOLE | 247,000 | 0 | 0 | ||
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 1,346 | 349,592 | SH | SOLE | 349,592 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 5,611 | 106,770 | SH | SOLE | 106,770 | 0 | 0 | ||
AFFIMED N V | COM | N01045108 | 190 | 92,500 | SH | SOLE | 92,500 | 0 | 0 | ||
AKEBIA THERAPEUTICS INC | COM | 00972D105 | 1,951 | 135,738 | SH | SOLE | 135,738 | 0 | 0 | ||
ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 2,531 | 221,013 | SH | SOLE | 221,013 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 132 | 5,500 | SH | SOLE | 5,500 | 0 | 0 | ||
APPLIED GENETIC TECHNOL CORP | COM | 03820J100 | 2,147 | 421,000 | SH | SOLE | 421,000 | 0 | 0 | ||
ARDELYX INC | COM | 039697107 | 1,904 | 373,409 | SH | SOLE | 373,409 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 262 | 15,550 | SH | SOLE | 15,550 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 848 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
ARQULE INC | COM | 04269E107 | 973 | 784,508 | SH | SOLE | 784,508 | 0 | 0 | ||
ARRAY BIOPHARMA INC | COM | 04269X105 | 167 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 922 | 33,214 | SH | SOLE | 33,214 | 0 | 0 | ||
ATRICURE INC | COM | 04963C209 | 9,316 | 384,145 | SH | SOLE | 384,145 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 3,287 | 73,036 | SH | SOLE | 73,036 | 0 | 0 | ||
BELLICUM PHARMACEUTICALS INC | COM | 079481107 | 234 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 3,287 | 591,128 | SH | SOLE | 591,128 | 0 | 0 | ||
BIOLINERX LTD | SPONSORED ADR | 09071M106 | 828 | 980,352 | SH | SOLE | 980,352 | 0 | 0 | ||
BIOTELEMETRY INC | COM | 090672106 | 2,509 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 840 | 8,000 | SH | SOLE | 8,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 4,155 | 82,000 | SH | SOLE | 82,000 | 0 | 0 | ||
CASCADIAN THERAPEUTICS INC | COM NEW | 14740B606 | 436 | 117,310 | SH | SOLE | 117,310 | 0 | 0 | ||
CELLECTIS S A | SPONSORED ADR | 15117K103 | 1,973 | 76,404 | SH | SOLE | 76,404 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 1,563 | 208,458 | SH | SOLE | 208,458 | 0 | 0 | ||
COGENTIX MEDICAL INC | COM | 19243A104 | 615 | 353,482 | SH | SOLE | 353,482 | 0 | 0 | ||
CONATUS PHARMACEUTICALS INC | COM | 20600T108 | 288 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 110 | 19,067 | SH | SOLE | 19,067 | 0 | 0 | ||
DERMIRA INC | COM | 24983L104 | 2,200 | 75,500 | SH | SOLE | 75,500 | 0 | 0 | ||
DERMIRA INC | NOTE 3.000% 5/1 | 24983LAA2 | 1,665 | 1,500,000 | PRN | SOLE | 1,500,000 | 0 | 0 | ||
DEXCOM INC | DBCV 0.750% 5/1 | 252131AE7 | 254 | 250,000 | PRN | SOLE | 250,000 | 0 | 0 | ||
EDGE THERAPEUTICS INC | COM | 279870109 | 199 | 19,400 | SH | SOLE | 19,400 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 284 | 35,977 | SH | SOLE | 35,977 | 0 | 0 | ||
EXACTECH INC | COM | 30064E109 | 689 | 23,136 | SH | SOLE | 23,136 | 0 | 0 | ||
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 1,650 | 355,667 | SH | SOLE | 355,667 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 2,954 | 38,609 | SH | SOLE | 38,609 | 0 | 0 | ||
GALENA BIOPHARMA INC | COM NEW | 363256504 | 27 | 46,145 | SH | SOLE | 46,145 | 0 | 0 | ||
GEMPHIRE THERAPEUTICS INC | COM | 36870A108 | 394 | 30,797 | SH | SOLE | 30,797 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 5,631 | 637,700 | SH | SOLE | 637,700 | 0 | 0 | ||
INOTEK PHARMACEUTICALS CORP | NOTE 5.750% 8/0 | 45780VAB8 | 369 | 600,000 | PRN | SOLE | 600,000 | 0 | 0 | ||
INOTEK PHARMACEUTICALS CORP | COM | 45780V102 | 451 | 237,135 | SH | SOLE | 237,135 | 0 | 0 | ||
INSULET CORP | COM | 45784P101 | 3,257 | 63,484 | SH | SOLE | 63,484 | 0 | 0 | ||
INSULET CORP | NOTE 2.000% 6/1 | 45784PAD3 | 2,746 | 2,250,000 | PRN | SOLE | 2,250,000 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | DBCV 2.250% 6/1 | 46333XAD0 | 767 | 573,000 | PRN | SOLE | 573,000 | 0 | 0 | ||
ISHARES TR NASDQ BIOTEC | ETF | 464287556 | 2,698 | 8,700 | SH | SOLE | 8,700 | 0 | 0 | ||
JOHNSON AND JOHNSON | COM | 478160104 | 1,244 | 9,400 | SH | SOLE | 9,400 | 0 | 0 | ||
LOXO ONCOLOGY INC | COM | 548862101 | 24,347 | 303,621 | SH | SOLE | 303,621 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 2,087 | 119,200 | SH | SOLE | 119,200 | 0 | 0 | ||
MASIMO CORPORATION | COM | 574795100 | 388 | 4,250 | SH | SOLE | 4,250 | 0 | 0 | ||
MINERVA NEUROSCIENCES INC | COM | 603380106 | 2,445 | 276,317 | SH | SOLE | 276,317 | 0 | 0 | ||
NATUS MDICAL INC DEL | COM | 639050103 | 295 | 7,900 | SH | SOLE | 7,900 | 0 | 0 | ||
NEOS THERAPEUTICS INC | COM | 64052L106 | 1,532 | 209,873 | SH | SOLE | 209,873 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 2,507 | 54,508 | SH | SOLE | 54,508 | 0 | 0 | ||
NEURODERM LTD | ORD SHS | M74231107 | 1,134 | 37,938 | SH | SOLE | 37,938 | 0 | 0 | ||
NXSTAGE MEDICAL INC | COM | 67072V103 | 5,418 | 216,119 | SH | SOLE | 216,119 | 0 | 0 | ||
OBSEVA SA | COM | H5861P103 | 214 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
PROTALIX BIOTHERAPEUTICS INC | NOTE 4.500% 9/1 | 74365AAB7 | 1,936 | 2,500,000 | PRN | SOLE | 2,500,000 | 0 | 0 | ||
RADIUS HEALTH INC | COM NEW | 750469207 | 2,411 | 53,309 | SH | SOLE | 53,309 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 1,211 | 443,478 | SH | SOLE | 443,478 | 0 | 0 | ||
SANGAMO THERAPEUTICS INC | COM | 800677106 | 1,980 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
SCYNEXIS INC | COM | 811292101 | 907 | 506,900 | SH | SOLE | 506,900 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM | 82640U107 | 310 | 265,000 | SH | SOLE | 265,000 | 0 | 0 | ||
SPECTRANETICS CORP | COM | 84760C107 | 2,146 | 55,896 | SH | SOLE | 55,896 | 0 | 0 | ||
SPRING BANK PHARMACEUTICALS | COM | 849431101 | 217 | 1,600 | SH | SOLE | 16,000 | 0 | 0 | ||
STEREOTAXIS INC | COM | 85916J409 | 796 | 1,372,862 | SH | SOLE | 1,372,862 | 0 | 0 | ||
SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 2,296 | 850,328 | SH | SOLE | 850,328 | 0 | 0 | ||
SYNERON MEDICAL LTD | ORD SHS | M87245102 | 941 | 85,947 | SH | SOLE | 85,947 | 0 | 0 | ||
TANDEM DIABETES CARE INC | COM | 875372104 | 579 | 724,286 | SH | SOLE | 724,286 | 0 | 0 | ||
TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 88 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
UNIQURE N V | SHS | N90064101 | 1,262 | 203,907 | SH | SOLE | 203,907 | 0 | 0 | ||
VOYAGER THERAPEUTICS INC | COM | 92915B106 | 1,835 | 204,808 | SH | SOLE | 204,808 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 1,190 | 377,695 | SH | SOLE | 377,695 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 809 | 55,809 | SH | SOLE | 55,809 | 0 | 0 |